Stocks / NASDAQ / Scienture Holdings Inc.

Scienture Holdings Inc.

Industry: Health Care – Other Pharmaceuticals

Stock Symbol: SCNX – NASDAQ

Animal Usage: Animal Testing

Our Opinion

Scienture Holdings Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following report that they exploit animals for product testing.

“Scienture has conducted two preclinical studies of SCN-104 and the SCN-104 injection pen: (i) a 30-day repeated dose toxicity study of dimethyl sulfoxide and caffeine following thrice daily, 3 times per week subcutaneous administration in Sprague-Dawley rats and (ii) a 30-day repeated dose toxicity study of dimethyl sulfoxide and caffeine following thrice daily, 3 times per week subcutaneous administration in Göttingen minipigs.” (Page 74) Read the full document

Company Description

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. Scienture Holdings, Inc. is based in Tampa, Florida.

Company Website: https://www.scienture.com

Contact: HoldingsIR@scienture.com